Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 4Unknown 2Completed 2Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Hemangioma 2Hemangioma, Cavernous 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × Timolol × Clear all
NCT02731287 2018-11-14

Topical Timolol for Infantile Hemangioma in Early Proliferative Phase

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 2 Completed
70 enrolled

Hemangioma

NCT02145884 2017-02-13

Topical Timolol Gel for the Treatment of Infantile Hemangiomas

Rady Children's Hospital, San Diego

Phase 2 Completed
26 enrolled

Hemangioma, Hemangioma, Cavernous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡